85-2651-39 Moxifloxacin Hydrochloride 25g CAS No:186826-86-8 257340
特徴
- Moxifloxacin Hydrochloride is the hydrochloride salt preparation of Moxifloxacin, an 8-methoxy-fluoroquinone compound with broad-spectrum bactericidal activity against gram-positive and gram-negative strains. 8-methoxy-fluoroquinones are described to inhibit the activities of DNA gyrase and topoisomerase IV. The 8-methoxy group of Moxifloxacin is suggested to confer a lowered propensity for resistance development as compared to other C-8 substituted quinolones, and Moxifloxacin demonstrates potent activity against wild-type and first-step gyrase- and topoisomerase IV-resistant mutants. Moxifloxacin shows activity against methicillin-susceptible staphylococci, penicillin-susceptible and penicillin-resistant pneumococci, penicillin-susceptible and penicillin-resistant viridans group streptococci, group A streptococci, M. catarrhalis, and H. influenzae in vitro.
- Identity (IR):Conforms to structure
- Related Substances:≤0.3%
- Sulfated Ash:≤0.1%
- Water:≤4.5%
- Solubility:Water, 5mg/ml, clear (warmed)
- Storage and Stability:May be stored at RT for short-term only. Long-term storage is recommended at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
仕様
- Size:25g
- Grade:Highly Purified
- Purity:≥98%
- Form:Supplied as a yellowish powder
- Molecular Formula:C21H25ClFN3O4
- Molecular Weight Non Ab:437.89
- EU Commodity Code:38220090
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- CAS No :186826-86-8
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-2651-37
Moxifloxacin Hydrochloride 5g
|
|
|
85-2651-40
Moxifloxacin Hydrochloride 50g
|
|
|
85-2651-39
Moxifloxacin Hydrochloride 25g
|
|
|
85-2651-41
Moxifloxacin Hydrochloride 100g
|
|
|
85-2651-38
Moxifloxacin Hydrochloride 10g
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





